Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-21

Clinical Trial Update: 4% Chlorhexidine Gluconate Daily Bathing for Prevention of Hospital-acquired Infections in Intensive Care Settings [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating daily bathing with 4% chlorhexidine gluconate to prevent hospital-acquired infections in intensive care settings has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorhexidine gluconate 4% (chlorhexidine gluconate)

Snippet

Sponsor: University Of Perugia | Conditions: Hospital Infection | Phase 4 | Status: COMPLETED